• No results found

UPTEC X 11 004

N/A
N/A
Protected

Academic year: 2022

Share "UPTEC X 11 004"

Copied!
1
0
0

Loading.... (view fulltext now)

Full text

(1)

UPTEC X 11 004

Date of issue 2011-02

Author

Hanna Garbergs

Title (English)

Extraction of therapeutic proteins from dried blood spots and their analysis on Gyrolab

Title (Swedish)

Abstract

A method for extraction of therapeutic proteins from dried blood spots (DBS) followed by quantification on GyrolabTM has been developed. The method makes it possible to measure the concentration of the analyte in the range 100-6000 ng/mL. The procedure can generate full analytical information from 15 µL blood originally sampled from a subject. The modest sample requirements allows for sampling a full pre-clinical pharmacokinetic profile from a single mouse. This may allow for reduced usage of animals during preclinical development of new therapeutic proteins in accordance with the 3R’s, replace, refine and reduce.

Keywords

Dried blood spots, immunoassays, therapeutic proteins, monoclonal antibodies, Gyrolab.

Supervisors

Mats Inganäs

Gyros AB

Scientific reviewer

Ola Söderberg

Uppsala University

Project name Sponsors

Language

English

Security

None

ISSN 1401-2138 Classification

Supplementary bibliographical information Pages

49

Biology Education Centre Biomedical Center Husargatan 3 Uppsala Box 592 S-75124 Uppsala Tel +46 (0)18 4710000 Fax +46 (0)18 471 4687

References

Related documents

Figure 8: Comparison of drug tolerance for GlyCLICK and amine labeled Humira. The plot shows the response on the y-axis and concentration of unlabeled drug on the x-axis. The

2.2.6 Alternative methods for estimation of target protein concentration in lysate Two different methods were used to verify the concentration estimated from the standard

Our main findings were that (1) the act of drying only slightly influenced detection of blood proteins (average correlation of 0.970), and in a reproducible manner (cor- relation

Human serum albumin, HSA, was crystallised in complex with a number of different ligands, including the fatty acid myristate. The crystallisation conditions were optimised to

what PG/Fz does even though it was difficult to draw conclusions on the concentration range. PG/Fz could quantify concentrations of IgG2b at lower concentrations than PG/Fz although

investigate the differences between the calculated concentrations of the analyte. As can be seen in Figure 15 Ahlstrom 226 DBS card generates in general a slightly higher

A method for extraction of proteins from dried blood spots (DBS) for analysis using Proseek is developed and evaluated. DBS, as sample format, possesses a number of

Gyrolab Bioaffy 1000 Gyros Protein Technologies (Uppsala) Gyrolab Bioaffy 1000HC Gyros Protein Technologies (Uppsala) Gyrolab Bioaffy 200 Gyros Protein Technologies (Uppsala)